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by 
Rebecca Joy Schlisner 
Under the Direction of W. William Walthall 
ABSTRACT 
 
 The over-expression of Down syndrome cell adhesion molecules (DSCAMs) is 
partially responsible for the mental retardation associated with Down syndrome.  
Previous work in our lab showed that a DSCAM homolog in C. elegans, Y32G9A.8, is 
expressed at all developmental stages and appears to be crucial for survival.  In an effort 
to map the expression pattern, I used the Genome Sciences Centre’s primer design 
program (http://elegans.bcgsc.bc.ca/gfp_primers/) to design a GFP promoter fusion 
product that was used to monitor gene expression.  The results indicate that Y32G9A.8 is 
expressed in the animal’s gut, suggesting that it may function in the worm’s innate 
immune response.  I also designed a primer set to amplify the Y32G9A.8 transcript. RT-
PCR of the entire Y32G9A.8 coding region resulted in a single product; there appears to 
be no alternative splicing.  Although this gene shows homology to other N-CAMS, 
results indicate that this gene may function in the innate immune system of C. elegans. 
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INTRODUCTION 
C. elegans is a free-living, non-parasitic soil nematode that is commonly used in 
the laboratory for genetic study and manipulation.  It is inexpensive and easy to maintain 
in the laboratory, feeding on bacteria, and large numbers of animals can be grown on a 
single Petri dish.   It is small (about 1 mm in length) and transparent for ease of 
manipulation and observation.  C. elegans has five pairs of autosomes and one pair of sex 
chromosomes; it has two sexes, hermaphrodites (XX) and males (XO).   Hermaphrodites 
can self-fertilize and are quite prolific--one hermaphrodite can produce over 300 progeny 
through self-fertilization.  In nature, hermaphrodites are the most common sex, with 
males being spontaneously produced about 1/1000 of the time due to non-disjunction of 
the sex chromosomes. In addition, C. elegans has a short life cycle.  From egg to egg 
takes about 3 days, and its life span is around 2 to 3 weeks under appropriate conditions. 
C. elegans’ short reproductive cycle makes it an ideal organism for genetic crosses and 
manipulations (1).  
C. elegans has a simple body structure and a small number of cells:  959 somatic 
cells including 302 neurons.  Because the body of C. elegans is transparent, it is easy to 
visualize individual cells using reporter genes that produce a visible gene product in the 
animal.  The nervous system has been studied extensively, and the complete cell lineage 
of the nervous system, as well as the other somatic cells, can be mapped from fertilization 
(2).  There appears to be no variation between animals in the branching structures of the 
neurons and the connections they make; this feature makes C. elegans an ideal model 
system for studying neural cell development because all animals show the same 
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patterning of neurons.  Classification of the neurons is based on cell morphology and 
synapse connectivity, and there are 118 distinct neuronal classes in C. elegans (2). 
Nervous System Development 
Early in development of the nervous system, it is critical that neurons are directed 
as to which way they should migrate.  The extracellular surroundings of neurons play a 
key role in guiding neural cell migration.  Axonal outgrowth is directed by means of 
mechanical guidance in which cell adhesion plays an important role in building neuronal 
connections (3).  Close contact between neighboring cells, i.e. cell adhesion, helps 
neurons form precise, highly specific circuits by directing axons towards their target 
cells.  Proteins found on the surface of developing neural cells, cell adhesion molecules 
(CAMS), help form adhesive molecular bonds between adjacent cells.  These highly 
specific bonds help to create the highly structured neural pathways that are necessary for 
proper development of the nervous system (3).   
The molecular signals produced by the binding of CAMs trigger signaling 
cascades within target cells which subsequently activate cellular kinases and raise cellular 
levels of Ca2+, both of which influence neuronal migration.  Migration of neurons is also 
influenced by chemical gradients that are established when target cells secrete soluble 
factors.  Secreted proteins, made by the target cell, can either attract or repel a growing 
axon, thereby guiding the formation of neural connections (3).      
Cell Adhesion Molecules (CAMs) 
An important group of proteins that are involved in building the correct neural 
circuitry are the cell adhesion molecules (CAMs).  CAMs are integral membrane proteins 
that facilitate connection of one cell to another through binding of CAMs on one cell to 
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CAMs on an adjacent cell (4).  CAMs are very important during development for guiding 
axons in finding their intended target neuron (3).  There are three major families of cell 
adhesion molecules having three common features:  an extracellular domain, a 
transmembrane domain, and a cytoplasmic domain.  Members of the three families of 
CAMs are specialized to specific tissues and functions and they include:  1. the cadherins, 
which bind to other cadherins (i.e. homophilic binding) in a calcium-dependent manner, 
are vital in early embryonic tissue development, 2.  selectins, which are mainly expressed 
on leukocytes and endothelial cells and are involved in immune reactions, and 3.  
immunoglobulin-like adhesion molecules, which can undergo both homophilic and 
heterophilic binding thereby binding a wide diversity of cell types that are involved in 
early neural development.  The integrins, a related class of proteins, have a structure 
similar to the CAMs, but they are substrate adhesion molecules.  Integrins play an 
important role in cell signaling by providing a link between the cytoskeleton and the 
extracellular matrix, binding to components of each (4).   
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Figure 1.  Immunoglobulin Superfamily Protein (Lawson, 2003) 
  
Ig molecules consist of two light and two heavy protein chains, each of which has 
a constant domain and a conserved domain (6). The immunoglobulin family of CAMs 
includes a large group of molecules that are generated from a smaller number of genes by 
alternative splicing; these proteins bind to various cellular receptors in a calcium-
independent manner.  Immunoglobulin (Ig) CAMs all contain one or more Ig domains, 
which are typically 70-110 amino acids long with conserved cysteine and tryptophan 
residues that are involved in binding to a wide variety of different CAMs on adjacent 
cells (6).  The most extensively studied members of this group are the neural cell 
adhesion molecules (N-CAMs) which are expressed primarily in nervous tissue and are 
involved in early neural development (4).     
   Neural cell adhesion molecules (N-CAMs) of the Ig superfamily maintain groups 
of cells at key sites during early development and in adult organisms (7). The neural cell 
adhesion molecules are expressed primarily, but not exclusively, in nervous tissue and are 
Intracellular 
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involved in setting up the early circuitry of the nervous system (4).  These N-CAMs of 
the Ig superfamily maintain groups of cells at key sites in the brain and skeletal muscle 
by mediating adhesion (through cell-to-cell contact), guidance, and differentiation during 
neuron growth.  Additionally, the homophilic binding of N-CAMS to other N-CAMs on 
target cells leads to signaling events that result in changes in gene expression (6, 7).  The 
role of N-CAMs in neural development has been studied in invertebrate species, such as 
C. elegans, as well as vertebrate species, such as M. musculus (6).  N-CAMS are Ig-like 
neuronal surface glycoproteins that bind to other CAMs.  In addition to their adhesive 
properties, binding of N-CAMs can affect intracellular signaling.  One example of 
intercellular signaling involving N-CAMs is a calcium-dependent signal transduction 
pathway that is triggered by N-CAMs binding in homophilic manner; this pathway 
ultimately leads to the activation of the fibroblast growth factor receptor (FGFR) (8).  
The FGFR family of receptor tyrosine kinases is expressed widely in the developing 
nervous system and activation of the receptor results in neurite outgrowth (8).   
Another pathway that involves homophilic N-CAM binding leads to the activation 
of the mitogen-activated protein kinase pathway.   In addition, cyclic adenosine 
monophosphate and protein kinase A are involved in N-CAM-mediated signaling (8).  
Also, several downstream effector molecules leading to N-CAM-mediated cellular 
endpoints have been established, including transcription factors and regulators of the 
cytoskeleton (8).  Their ability to influence developmental events, including cell 
migration, proliferation, and differentiation can therefore result both from their adhesive 
as well as their signaling properties.  Mutations in N-CAM genes can lead to human 
genetic diseases including mental retardation and nervous system disorders (7).  
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Down syndrome cell adhesion molecules (DSCAMs) are a specific type of N-
CAM that is vital for early neural differentiation and development in organisms as 
diverse as Drosophila and humans (9).  DSCAMs are involved in guiding dendritic and 
axonal processes during early neural development of the central and peripheral nervous 
systems in humans (9).  An overabundance of these DSCAMs is believed to contribute to 
the mental retardation and some of the other health problems associated with Down 
syndrome in humans (9).   
Genetic Contributions to the Development of the Nervous System 
In order to form precise neural connections, it is necessary for an organism to 
have many different CAMs in its protein repertoire.  However, this poses a problem for 
organisms that have a relatively small genome size; these organisms cannot have a single 
gene to code for each specific CAM.  A DSCAM homolog in Drosophila melanogaster 
has more than 38,000 different alternative splice products (10), which may solve the 
problem of having only a few genes with which to create a complex nervous system. 
Drosophila accomplishes this by having its alternatively spliced exons arranged in four 
clusters, each of which is spliced in a mutually exclusive manner.  The other exons in the 
gene are constitutively spliced in the mRNA (10).   On the other hand, the human, with 
more genes than Drosophila, has DSCAMs with only a few splice variants (11); even 
though humans presumably have a much more complex nervous system than Drosophila. 
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Figure 2.  Organization of the D. melanogaster Dscam gene (Celotto et al., 2001) 
 
Innate Immunity in C. elegans 
Unlike vertebrate species that have both an innate immune system and a highly 
developed acquired immune system involving the formation of antibodies, C. elegans has 
only an innate immune system for immune protection against invading pathogens.  
Antibodies that are responsible for an acquired immune response are members of the 
immunoglobulin superfamily of proteins.  This type of response is highly specific; each 
antibody only recognizes a single antigen.   In higher vertebrates, there is a highly diverse 
protein repertoire of antigen-specific receptors that are created by somatic gene 
rearrangement and clonal selection.  Invertebrates, however, do not make the large array 
of diverse antibodies seen in vertebrates.  Instead, they may use the method of alternative 
splicing of an Ig-like molecule to produce a large protein repertoire to deal with specific 
immunity (12).  
Because C. elegans lacks any cellular immunity, these animals produce peptides 
called antibacterial factors (ABFs) that act in an antimicrobial capacity and are 
constitutively expressed in the animal.  Regulation of gene expression is altered in C. 
elegans following infection by a pathogenic microorganism.  Bacteria that infect the 
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worm’s intestine induce genes that code for antimicrobial peptides such as lysozymes.  
Cells of the intestinal wall are thought to secrete these antimicrobial peptides into the 
intestinal lumen so the peptides can specifically target any invading pathogens that are 
present there (13).  
The largest group of surface receptor proteins found in animals is the 
immunoglobulin (Ig) superfamily of proteins.   These proteins may play several roles 
including cell-adhesion and cell signaling (12).  In Drosophila a Down syndrome cell 
adhesion molecule (DSCAM) gene, a member of the Ig superfamily, has been identified 
as an important component responsible for wiring neural circuitry (12).  This gene 
undergoes alternative splicing to produce more than 19,000 protein variants differing in 
their extracellular domains; this would allow for recognition of numerous different 
ligands on diverse surface receptors.  Watson et al. found that DSCAM is also expressed 
in Drosophila fat body cells, cells which constitute an important component of the fly’s 
immune system (12).  Fat body cells are also important in humoral immunity in 
Drosophila because they secrete antimicrobial proteins that provide some defense against 
pathogens.    Microarray analysis of gene expression revealed that different and distinct 
subsets of exon sequences were found in fat body cells compared to cells derived from 
brain tissue (12).  Several secreted forms of the DSCAM protein were also found in 
extracts from fat body cells and are thought to circulate in the hemolymph (12) 
C. elegans has several different cell-signaling pathways that are important to the 
worm’s innate immune system.  One such pathway is the DBL-1 pathway, a pathway that 
is homologous to the TGF-β pathway in mammals; animals that have mutations in this 
pathway are vulnerable to infection by pathogenic bacteria. Another important pathway, 
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the DAF-2 (abnormal Dauer formation)/IGF (insulin-like growth factor) pathway, 
regulates aging in C. elegans.  DAF-16, a transcription factor, is inhibited by DAF-2.  
Several antimicrobial genes are the targets of DAF-16, so inhibition of this transcription 
factor would presumably downregulate these important genes (14).     
Toll-like receptors (TLRs) are an important component of the innate immune 
system of many organisms.  These proteins are transmembrane proteins that have an 
extracellular leucine rich repeat domain and an intracellular Toll/interleukin-1 receptor 
(TIR) domain (15).  These TIR-containing proteins activate signal transduction pathways 
that are important for innate immunity in animals as well as plants (16).   C. elegans has 
one Toll homolog, tol-1, and homologs to other NFkB signaling genes that are involved 
in the Toll signaling pathway. Pujol et al (2001) found that tol-1 functions in pathogen 
recognition and avoidance in C. elegans.   
 
 
 
 
*www.wormbase.org 
Figure 3.  Organization of Exons in the Y32G9A.8 Gene in C. elegans 
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Characterization of Y32G9A.8 
Y32G9A.8, a putative expressed gene in C. elegans, was identified by performing 
a BLAST search using a known human IgG domain from a Herpes Simplex 1 receptor 
(17). The Y32G9A.8 gene is located on chromosome V, and the genomic DNA contains 
6,042 nucleotides, with 6 predicted exons. Y32G9A.8 is related to the zig gene family 
that is involved in axonal development in C. elegans.    Surprisingly, Y32G9A.8 is more 
closely related to a DSCAM in humans than any C. elegans gene (17). Figure 3 shows the 
organization of Y32G9A.8 in C. elegans.   
 
 
* www.ncbi.nlm.nih.gov 
Figure 4.  Organization of CHD2, a Human DSCAM with Two Isoforms  
 
The predicted protein of Y32G9A.8 has 304 amino acids and has 41.1 % 
similarity to the amino acid sequence of CHD2-52 (a DSCAM in humans) in an IgCAM 
domain consisting of 56 amino acids.  CHD2-52 is a transcript variant of CHD2, a 
DSCAM precursor; this variant lacks an alternate segment compared to variant 1 that 
causes a frameshift mutation. The resulting isoform (CHD2-52) is shorter and has a 
distinct C-terminus compared to isoform CHD2-42.  Isoform CHD2-52 may be secreted 
rather than membrane-bound as is isoform CHD2-42 (17). The organization of these 
human DSCAM isoforms and their coding segments is illustrated in Figure 4.  ZIG-1, a 
C. elegans protein containing an IgCAM domain, has 28.2 % similarity to Y32G9A.8 
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(17).  The predicted protein of Y32G9A.8 has three Ig domains and one Ig-like domain, 
but the protein has not been isolated (17).    Since the size of the C. elegans genome is 
similar to that of Drosophila, one might predict that Y32G9A.8 gives rise to many 
alternative splice variants.  But since this putative gene is more similar to the human 
DSCAM, it may only have a few variants.  Figure 5 shows the predicted protein with its 
functional domains.  
 
 
 
First, it was necessary to find out if Y32G9A.8 is a gene that is actually expressed 
in C. elegans.  Previous work in the lab partially characterized the expression of this 
gene.   Northern dot blot and RT-PCR (using a probe and primer for exon 4) analysis 
showed that Y32G9A.8 is transcribed at all larval stages in C. elegans (17). After 
determining that Y32G9A.8 is a transcribed gene, it was important to determine if it is 
necessary for survival and normal function in C. elegans.  RNAi experiments, using both 
soaking and microinjection, indicate that the gene product is essential for normal function 
in the adult worm (17).  Treated worms exhibited a high mortality rate, while those that 
survived exhibited uncoordinated, lethargic movement.  Control animals, alternatively, 
exhibited a considerably higher survival rate and normal phenotype (17).  I have 
attempted to extend this work and determine the expression pattern of Y32G9A.8 by 
Signal 
Peptide 
1 20N C
  135                      230                        301 - 304
                   Figure 5.  TheY32G9A.8 Putative Protein in C. elegans                         
Amino Acid 
Immunoglobulin-like 
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isolating the promoter and characterizing it.  I have created a GFP reporter construct by 
fusing the gene’s putative promoter to a GFP coding region from a GFP expression 
vector.  By determining the expression pattern of this gene, we will be one step closer to 
determining this gene’s normal function in C. elegans.  I initially expected to see 
Y32G9A.8 expressed at high levels in cells of the nervous system, and I expected to find 
that multiple splice variants were produced.  
Y32G9A.8, a partially characterized gene in C. elegans, was further characterized 
by determining the gene’s expression pattern and the number of splice variants produced.  
Previous bioinformatics analysis and RNAi experiments indicate that this gene is a 
DSCAM homolog that is important for normal development in C. elegans; these analyses 
suggest that the gene is expressed in the nervous system.  Results of the expression 
pattern analysis, however, indicate that Y32G9A.8 is expressed in the worm’s intestine.  
Because expression seems to be localized to the worm’s intestine, it is likely that this 
gene is involved in innate immunity.  Proteins involved in C. elegans’ innate immune 
system are normally expressed in the animal’s gut.  Furthermore, analysis of the number 
of splice variants indicates that the gene is structurally more similar to human DSCAMs 
than those of Drosophila. 
MATERIALS AND METHODS 
 One strain of animal was used for DNA isolation, RNA isolation, and 
microinjection.  Him-5 animals exhibit wild-type phenotype, but they produce 20% males 
in their offspring due to non-disjunction of the X chromosome.  Typically, wild-type 
animals produce 0.1% males.  The basic C. elegans anatomy is shown in figure 6. 
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Figure 6.  Anatomy of a Hermaphrodite (avery.rutgers.edu) 
   
him-5 worms were grown on NGM agar plates (0.3% NaCl, 2.5% peptone, 1.7% 
agarose, 5µg/mL cholesterol, 1mM CaCl, 1mM MgSO4, 25mM KHPO4) containing 
OP50 bacteria (an E. coli strain) as food.  Worms were transferred to fresh NGM plates 
every 7-10 days to prevent overcrowding of the plates.  Worms were kept in a sterile 
20˚C incubator.   
Genomic DNA Isolation  
 Genomic DNA was isolated from a mixed population of him-5 worms.  Five mL 
of 200 mM Tris-Cl/100 mM EDTA/400 mM NaCl was pipetted onto four 60x15 mm 
NGM plates containing him-5 worms.  The solution was pipetted and put into two 15-mL 
sterile Falcon tubes.  The worm solution was centrifuged in an IEC clinical centrifuge at a 
setting of 5 for 3 minutes.  The supernatant was removed, and the worm pellet was 
washed by the addition of 5 mL of 200 mM Tris-Cl/100 mM EDTA/400 mM NaCl to the 
pellet.  The solution was pipetted up and down several times and re-centrifuged as before, 
removing the supernatant after centrifugation.  This wash was repeated 3 more times to 
remove any remaining bacteria.  The worms were then transferred to a 1.5-mL 
microcentrifuge tube and centrifuged at 12,000 g for 1 minute at room temperature.  The 
liquid was then removed from the pellet by aspiration.  The pellet was placed on dry ice 
for 10 minutes and then thawed by the addition of 0.5 mL nematode lysis buffer 
14 
 
equilibrated to 65˚C.  The mixture was pipetted up and down through a cut-off P-1000 
pipette tip and then inverted to mix.  After mixing, the nematode mixture was incubated 
at 65˚C for 1 hour and inverted every 20 minutes.  The worm lysate was extracted twice 
with one volume TE-saturated phenol.  The lysate was then extracted with one volume of 
chloroform to remove any remaining phenol.  Worm DNA was precipitated with 1/3 
volume 7.5 M ammonium acetate (pH 7.4) and 2.5 volumes absolute ethanol.  The DNA 
was incubated at -20˚C for 30 minutes and then centrifuged at 14,000 rpm for 15 minutes.  
The DNA pellet was washed with 70% ethanol and re-centrifuged for 10 minutes, after 
which the pellet was allowed to air dry for 5 minutes.  Fifty µL of TE buffer was added to 
the pellet to resuspend the DNA.  The DNA solution was diluted 1:1000 and the 
concentration was measured using a UV spectrophotometer.   
GFP Reporter Constructs and Expression Analysis 
 Reporter gene constructs are often used to produce transgenic animals for analysis 
of gene expression patterns.  GFP, the green fluorescent protein isolated from the 
jellyfish Aequorea victoria, is used to visualize gene expression patterns in a variety of 
animal species including C. elegans (18).  In a reporter gene construct, the promoter of a 
gene of interest is fused to a reporter gene, such as GFP, whose gene expression is clearly 
visible.  In the transgenic animal, the gene of interest should be present wherever the 
reporter gene is expressed.   The sensitivity of GFP reporter constructs allows one to 
visualize gene expression in a single cell (19), and because worms are semi-transparent, 
visualization of GFP expression is straightforward.   
 There are two types of reporter gene constructs: ones that show transcriptional 
expression and those that show translational expression.  Transcriptional reporter gene 
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constructs consist of a gene’s promoter fused directly to the reporter gene, whereas 
translational reporter constructs consist of the promoter, the entire gene, and the reporter 
gene fused together (20).  Traditional reporter gene constructs are produced by 
subcloning a PCR product (promoter or promoter + gene) into a GFP expression plasmid.  
This subcloning strategy, however, is time-consuming and not feasible for high-
throughput gene expression analysis.   
 An alternative method for creating GFP reporter constructs is that of fusion-PCR, 
or stitching.  Fusion-PCR is a quick, effective method for producing GFP reporter 
constructs on a large scale (19).  The PCR fusion method negates the need for timely 
subcloning and DNA purification methods.  With fusion PCR, two separate PCRs are 
performed in parallel; one reaction amplifies the gene-of-interest’s promoter, while the 
other amplifies GFP from a GFP expression vector.  The concentrations of each of these 
products are estimated by gel electrophoresis, and approximately 10-50 ng of each PCR 
product is used as the template for the fusion PCR.  Nested primers are used for the 
fusion PCR.  The downstream primer for the gene’s promoter, primer B, is designed with 
a 24 bp overhang which is complementary to the 5’ end of the GFP PCR product.  This 
overlapping region allows the two separate PCR products to hybridize and serve as a 
template for the subsequent fusion or stitching of the products (18).   With this method, a 
reporter construct can be constructed and ready for microinjection within a single day, 
providing that the correct PCR conditions are known and the reactions are successful.   
Figure 7 illustrates the method for creating a reporter construct by PCR fusion. 
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Figure 7.  Diagram of Fusion PCR Method.  The templates are worm genomic DNA 
(PCR#1) and the GFP expression vector pPD117.01 (PCR #2).  In PCR #3, nested 
primers were used to create the GFP promoter fusion product using products from PCRs 
1 and 2 as the template.  
 
 
Promoter Isolation and Vector Construction 
In order to look for the spatial and temporal gene expression pattern of 
Y32G9A.8, I generated a GFP fusion vector using a novel method developed by Hobert 
that utilizes PCR to generate overlapping sequences between the promoter sequence and 
the GFP coding sequence (18).  Both the promoter region and the GFP region were first 
Y32G9A.
1673bp
GFP
1511 bp 
 
promoter GFP
F3 
         F2 
2900 or 2750 bp
Step 2.  PCR using primers for GFP—the F primer also 
contains sequences complementary to the promoter 
Step 3.  Combined PCR to generate fusion product 
Step 1.  PCR using primers for promoter
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amplified separately.  Then, since the 3’ end of the promoter sequence and the 5’ end of 
the GFP sequence were complementary (resulting from the primers used), I combined the 
two products and used primers on the 5’ end of the promoter and 3’ end of the GFP to 
make a composite DNA sequence that consisted of the promoter for Y32G9A.8 fused to 
the coding region for GFP.  The construction of this fusion product is outlined in figure 6.   
 PCR was performed on the genomic worm DNA using a set of primers that were 
named PVLR/05-F1 & PVLR/06-R2.  The primers were designed using the Genome 
Sciences Centre’s sequence annotation-directed PCR primer design program 
(http://elegans.bcgsc.bc.ca/gfp_primers/), and they were designed to amplify the putative 
promoter of the Y32G9A.8 gene, a region upstream from the gene that is 1685 bp in 
length.  Genomic worm DNA that was previously isolated was used as the template for 
PCRs using the PVLR primer set.  The final concentration of MgCl2 that was used for the 
reactions was 3 mM.  A series of reactions with varying concentrations of MgCl2 were 
prepared and run in an Eppendorf Mastercycler Gradient thermal cycler.  The 
temperature gradient that was used for the annealing temperature of the reactions was 47° 
-67° C.  Reactions with a final MgCl2 concentration of 3mM and an annealing 
temperature of 59.1° C produced the most prominent band when samples were run on a 
gel.  For subsequent reactions, the thermal cycler was set for the following cycle:  5 
minutes at 95˚C, then 35 cycles of 1 minute at 95˚C, 1 minute at 59.1˚C, and 1.5 minutes 
at 72˚C.  The PCR products were electrophoresed on a 1% agarose gel stained with 
ethidium bromide.                                          
PCR was also performed using pPD117.01, a GFP expression plasmid, as a 
template.  Figure 8 shows a map of the pPD117.01 expression plasmid.  The primers for 
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this PCR were designed using the Primer3 Input program (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi), and they were called pPD117-F and pPD117-R2.  A 
nested primer, pPD117-R1 was also designed using this program.  These primers were 
designed to amplify a region approximately 1500 bp in length which included the GFP 
coding region.  The forward primer pPD117-F was designed to have a 24-bp region on its 
5’ end which overlaps with the 3’ region of the PVLR promoter fragment.  Products from 
this reaction were electrophoresed on an agarose gel to confirm their size and estimate 
their concentration. 
 
7  Sph I
12  Sse 8387I
13  Pst I
19  HinC II
19  Sal I
25  Xba I
31  Sac II
41  Asc I
42  BssH II
630  Bsm I
710  Sac I
890  [mec7 5']
903  BamH I
909  Cla I
918  Not I
919  Eag I
932  Sma I
945  [T7p]
959  Kpn I"
962  Age I
978  [gfp-N]
1140  Nco I
1140  Sty I
1165  [SynIVS]
1216  [S65C]
1238  Xho I
1370  [SynIVS]
1585  [SynIVS]
1830  [gfp-C]
1857  EcoR I
1863  Nhe I
1867  NgoM I
1884  BspE I
2019  [let858 3']
2270  Spe I
Apa I  2324
Sfi I  2325
Stu I  2333
Nar I"  2348
Aat II  2354[AmpR C]  2621
AmpR N]  3333
[ColE1Ori]  4095
BspLU11I  4165
[decoy]  4609
L3691 pPD117.01
4640 base pairs
Selected Unique Sites
 
Figure 8.  GFP Expression Plasmid pPD117.01.  pPD117.01 was used as a template to 
amplify its’ GFP coding region which was used to create a GFP promoter fusion product.  
The primers used, pPD117-F and pPD117-R2, were designed to amplify a region 
approximately 1500 bp in length which includes the GFP coding region as well as a 3’ 
UTR (let858) that facilitates GFP expression. 
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The resulting PCR products from the PVLR and pPD117 reactions were 
subsequently used as templates for the fusion PCR.  One µL of each product was added 
to the fusion reaction to serve as the template.  The nested primers PVLR/05-F2 (or F3) 
and pPD117-R1 were used in the fusion PCR. These reactions were expected to produce 
products approximately 2900 or 2750 bp in length, respectively.  The fusion PCR method 
that was used is outlined in Figure 6.   The sequences of the PCR primers are given in 
Table 1.   
 
Table 1.  PCR Primers used for Fusion PCR 
 Sequence 
PVLR/05-F1 5’AGATGAAACCCGACAGGAAAT 3’ 
PVLR/05-F2 5’ACGAAAAAGCGGTGGAAAAT 3’ 
PVLR/05-F3 5’TGCGCAAAACGTATTCTCAG 3’ 
PVLR/06-R2 5’TCTTGATTGGCTCTTCTGTACG 3’ 
pPD117-F 5’ACCGTACAGAAGAGCCAATCAAGAGGTGCCCTATAGTGAGTCGT3’
pPD117-R1 5’CTCATCGTTCGCCTAATTTC 3’ 
pPD117-R2 5’TGTCTCATGAGCGGATACAT 3’ 
  
* overlapping region 
 
 
Microinjection and Transformation 
 Transgenes can be introduced into an organism in order to observe their effects in 
vivo.  This type of genetic manipulation has been used in bacteria, yeast, cultured 
mammalian cells, as well as multicellular organisms such as Drosophila and C. elegans.  
In the case of multicellular organisms, the transforming DNA is usually delivered by 
microinjection into a fertilized egg, or, with C. elegans, into the gonad.  By introducing 
transgenes, one can study the temporal and spatial expression of newly introduced 
sequences (21).   
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C. elegans is an ideal organism for the use of DNA transformation by 
microinjection.  The injection of both linear and circular DNA into adult hermaphrodites 
can lead to the formation of stably inherited extrachromasomal DNA arrays and the 
creation of transgenic animals which can be used for further screening (22).  The most 
effective method of producing transgenic worms is by injecting DNAs into the distal part 
of the gonad.  Because C. elegans has a syncytial gonad, injected DNAs can be passed on 
to many offspring (22).   
 The GFP-promoter fusion DNA was microinjected into the syncytial gonad of 
adult animals.  250 ng of reporter DNA was dissolved in 5 µL of 1X microinjection 
buffer (2% polyethylene glycol, 20mM potassium phosphate, pH 7.5 and 3mM potassium 
citrate, pH 7.5).  The DNA concentration was increased to 100 ng/µL using genomic 
worm DNA as carrier DNA.  The needles used for microinjection were physically broken 
by pushing the needle against the edge of a coverslip.  This was done after loading the 
needle with the prepared DNA solution.  Several adult hermaphrodites were mounted on 
a 2% agarose pad containing Halocarbon microinjection oil. Once the animals were stuck 
to the pad, the agarose pad was placed on the injection table and the animals were 
injected with the DNA solution.  Injected animals were recovered to a fresh NGM plate 
containing food following a brief soaking (~10-15 min.) in recovery buffer (M9 plus 4% 
glucose).  Offspring of the injected animals were observed 48 and 72 hours following 
microinjections.  Animals were observed for GFP expression using a Zeiss fluorescent 
stereoscopic microscope. 
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Analysis of Alternative Splice Products 
 Total RNA was isolated from a mixed population of him-5 worms growing on 
NGM plates seeded with OP50 bacteria.  Worms were rinsed from ten 100x15 mm NGM 
agar plates using 5 mL of DEPC-treated water to remove them.  The worms were pipetted 
into 15 mL sterile Falcon tubes.  The worm solution was centrifuged at a setting of 5 in 
an IEC clinical centrifuge for 3 minutes, after which the supernatant was removed and the 
pellet was washed 4 times with 10 mL DEPC-treated water.  The pellet was aspirated to 
remove as much liquid as possible and placed on dry ice for 10 minutes.  The worm 
pellets were thawed on ice and 4 mL of Trizol was added to 1 mL of packed worms in 
each 15-mL tube.  The tubes were vortexed vigorously for 1.5 minutes, and the worm 
mixture was frozen and thawed for 2 cycles on dry ice. After the final freezing, the pellets 
were thawed on ice, and an additional 2 mL Trizol was added to each tube and vortexed 
vigorously for 1.5 minutes.  Two mL chloroform was then added to each tube, and the 
tubes were shaken for 15 seconds and incubated at room temperature for 3 minutes.  The 
worm lysate was aliquotted into RNase-free tubes and centrifuged at 12,000 g for 15 
minutes.  The top aqueous layer was removed to fresh tubes, and an equal volume of 
RNase-free isopropanol was added to each tube and mixed by inverting.  The mixture 
was allowed to incubate at room temperature for 10 minutes, after which the samples 
were centrifuged at 12,000 g for 10 minutes.  Following centrifugation, the RNA pellets 
were washed with 75% ethanol (made with DEPC-treated water) and re-centrifuged at 
7500 g for 5 minutes.  After washing the pellets, the supernatant was removed, and the 
pellets were air-dried for 10 minutes.  RNA pellets were dissolved in 10 µL RNase-free 
water and incubated at 60˚C for 10 minutes.  The RNA solutions were combined in one 
22 
 
1.5 mL microcentrifuge tube, and the concentration of the RNA solution was measured 
using a UV spectrophotometer.  A sample of the total RNA solution was electrophoresed 
on a non-denaturing agarose gel.   
 RT-PCR was performed using the StrataScript One-Tube RT-PCR kit and 
protocol.  The primers used, Y32G9A.8-F and R, were designed to reverse-transcribe and 
amplify 910 bp of the 915 bp Y32G9A.8 coding region.  Primers Y32G9A.8-F and R 
were designed to base pair with exons 1 and 6 respectively.  Another primer, F2-
Y32G9A.8, was designed approximately 50 bp upstream from exon 1 and was expected 
to amplify approximately 960 bases when used with the Y32G9A.8 reverse primer. 
Figure 9 illustrates the location of the primers in relation to the gene transcript.  A control 
reaction was prepared by adding the following to a PCR tube on ice:  40.5 µL RNase-free 
water, 5 µL 10X RT-PCR buffer, 1 µL control primer set (200 ng/µL), 1 µL dNTP mix 
(40 mM), 1 µL control mRNA (500 bp).  The experimental reaction was prepared by 
adding the following to another PCR tube on ice:  39.5 µL RNase-free water, 5 µL 10 
PCR buffer, 1 µL F-Y32G9A.8 primer (60 µM), 1 µL R-Y32G9A.8 primer (60 µM), 1 
µL dNTP mix (40 mM), 3 µL total worm RNA (0.26 µg/µL).  The StrataScript RT 
enzyme was diluted by adding the following to an RNase-free microcentrifuge tube on 
ice:  6.2 µL RNase-free water, 0.8 µL 10X RT-PCR buffer, 1 µL StrataScript RT (20 
U/µL).  One µL of the diluted RT enzyme was added to each PCR tube, followed by the 
addition of 0.5 µL Easy-A HiFi PCR cloning enzyme.  The samples were gently mixed, 
avoiding bubbles.  The samples were placed in a thermal cycler that was set as follows:  
42˚C for 60 minutes (RT reaction), 95˚C for 1 minute, followed by 40 cycles of 95˚C for 
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30 seconds, 53.5˚C for 30 seconds, and 68˚C for 2 minutes.  The RT-PCR samples were 
electrophoresed on a 1% agarose gel stained with ethidium bromide.    
 
                       Arrangement of Exons in Y32G9A.8 mRNA 
 
 
Figure 9.  Location of primers for RT-PCR within Y32G9A.8 transcript.  Arrows 
indicate the location of primers used for RT-PCR.  Primer Y32G9A.8-F is located 5 bp 
downstream from the transcription start site in exon 1.  Primer Y32G9A.8-F2 is 50 bp 
upstream from the transcription start site.  The reverse primer, Y32G9A.8-R (not labeled) 
is located at the end of exon 6 and was used for both RT-PCR reactions.  Total RNA was 
used as the template. 
 
 
RESULTS 
Construction of the GFP fusion proved to be difficult.  Throughout the 
experiment, the amplification of the promoter sequence was challenging and involved a 
lot of trial and error using different conditions of MgCl2 concentration and pH.   
However, this obstacle was overcome and sequencing of the PCR fusion product  
confirmed that I had indeed inserted the promoter region of Y32G9A.8 in frame with the 
GFP coding region (data not shown). 
Constructing the Promoter: GFP Fusion Product 
The primers used to amplify the promoter region are located at -1 bp (PVLR/06-
R2) and -1673 bp (PVLR./05-F1) from the translation start site, so the predicted size of 
the PCR product is 1673 bp.   A product of approximately 1700 bp in length was 
1 2 3 4 5 6 
F1 
F2 
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generated following PCR of the Y32G9A.8 promoter (Fig. 10) that corresponds with the 
predicted size.   Similarly, for the GFP PCR, the predicted size is 1511 bp, and following 
PCR using the PPD117-R2 and F primers a product of approximately 1500 bp in length, 
was detected (Fig. 10).  
 
Figure 10.  PCR to amplify Y32G9A.8 promoter sequence and GFP coding 
region.  Lane 5 was loaded with 5 µL of Bioline’s Hyperladder DNA marker.  
Lanes 1-4 contain the Y32G9A.8 promoter amplified by PCR using PVLR/05-F1 
as the forward primer.  Lanes 6-8 contain the Y32G9A.8 promoter amplified 
using PVLR/05-F2 as the forward primer.  Lanes 9 and 10 contain the GFP 
coding region amplified using the PPD117 primer set.   
 
Following PCR of the promoter, the amplified product was separated by gel 
electrophoresis and purified from an agarose gel.  The purified PCR product was sent to 
the Biotechnology & Drug Design Core Facility at Georgia State University for DNA 
sequencing.  This was done to ensure that the sequence of the amplified promoter 
matched the gene’s published sequence which is available at www.wormbase.org.  
 
 
1511 
F1 F2 GFPladder
2000 
1000 
1685 
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Sequencing of the promoter PCR product confirmed that the promoter matched the 
published sequence (results not shown).   
The next step was to generate the fusion product by combining the two individual 
pieces of DNA and performing the next round of PCR.  The fusion, or stitching, PCR 
resulted in a product approximately 2900 bp in length for the reaction using PVLR/05-F2 
as the nested primer (Fig 11).   When PVLR/05-F3 was used as the nested primer, the 
reactions produced products of the expected size (~2750 bp). 
  
                                         1                F2    F3             10 
2900
3675
23232750
 
 
Figure 11.  Fusion PCR to create Y32G9A.8 promoter:GFP fusion product.  Lane 1 
was loaded with 5 µL of Bioline’s Hyperladder DNA marker.  Lanes 2-5 contain the 
fusion PCR product using PVLR/05-F2 as the nested primer.  Lanes 6-9 contain a fusion 
PCR product using PVLR/05-F3 as the nested primer.  Lane 10 contains BstE II marker. 
 
 
Gel electrophoresis results indicate that a PCR product of the correct size was 
produced with each PCR reaction.  Both the PVLR and GFP PCRs produced products of 
the expected size.  When the two PCR products were used as templates for the fusion  
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PCR, it appears that the appropriate fusion product was produced based on the size of the 
fragments (2900 bp for the F2 forward primer and 2750 bp for the F3 forward primer).    
Observation of Fluorescence 
 Once the promoter fusion product was successfully produced, it was injected into 
the syncytial gonad of C. elegans in order to observe the gene’s expression pattern in 
offspring of the injected animals.  Adult worms were microinjected with a solution 
containing the GFP fusion DNA in 1X microinjection buffer.  After 48 hours, the worms 
were observed under a Zeiss fluorescent dissecting microscope for the presence of 
fluorescence in the form of GFP.  Twenty-four adult hermaphrodite animals were 
injected with the promoter fusion DNA, 14 of which survived 24 hours following 
microinjection.  Over 150 offspring were observed, only one of which showed the 
following GFP expression pattern.  This was a larval animal, pictured in figure 12, which 
showed GFP expression in the anterior region of its intestine. When the reporter-fusion 
construct was microinjected into adult animals, GFP expression was observed in the 
progeny; this indicates that the PCR fusion was successful.  Because GFP expression was 
observed, this also suggests that the minimal promoter for Y32G9A.8 was included in the 
reporter construct.   This GFP expression pattern was seen on the right side of the animal; 
however the left side of the animal showed no GFP expression in the same area of the 
gut, as shown in figure 13. After photographing this animal, it was recovered to a fresh 
NGM plate with OP50, but it did not survive to produce any offspring.   
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Figure 12. Lateral right view of expression of Y32G9A.8 in C. elegans as visualized 
by microinjection of GFP promoter fusion product (offspring of injected animal is 
pictured) 
 
 
Figure 13.  Lateral left view of expression of Y32G9A.8 in C. elegans as visualized by 
microinjection of GFP promoter fusion product (offspring of injected animal is 
pictured). 
 
 
Analysis of Alternative Splice Products 
Another important question was whether Y32G9A.8 produces a single transcript 
(similar to the human DSCAM) or multiple transcripts (as in Drosophila).  To answer 
this question RT-PCR was performed on total RNA isolated from C. elegans and 
amplified using primers designed for the predicted Y32G9A.8 transcript.  Total RNA was 
electrophoresed on a non-denaturing agarose gel stained with ethidium bromide.  The 
resulting gel, illustrated in figure 14, shows three prominent bands believed to correspond 
to rRNA bands.  The concentration of total RNA was calculated to be 2.6 µg/µL.  This 
isolation of total RNA was used for subsequent RT-PCR experiments.  
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Figure 14.  Isolation of total RNA.  Total RNA was isolated using Trizol and 
electrophoresed on a non-denaturing agarose gel. 
 
RT-PCR primers (Y32G9A.8-F1 & R) were designed to span the length of the 
Y32G9A.8 transcript.   Another forward primer, Y32G9A.8-F2, was designed to be 50 bp 
upstream from Y32G9A.8-F1 and is located just upstream of exon 1; this was done to 
determine if the first exon is alternatively spliced.  The location of the RT-PCR primers is 
outlined in figure 9.  Total RNA was used as the template for RT-PCR using the 
StrataScript One-Tube RT-PCR kit and protocol.  The positive control reaction included 
a 500 bp mRNA molecule which was included in the kit.  A negative control was 
performed by omitting the RNA template from the reaction.  RT-PCR using the 
Y32G9A.8-F1 & R primer set produced a single PCR product approximately 910 bp in 
length, as shown in figure 15.  The control reaction produced a 500 bp PCR product as 
expected.  RT-PCR using Y32G9A.8-F2 as the forward primer produced a single product 
of approximately 960 bp which corresponds to the expected size and is illustrated in 
figure 15.  RT-PCR was repeated using the Stratascript RT-PCR kit, and a single RT-
PCR product was produced again (results not shown).   
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Figure 15. RT-PCR to analyze alternative splicing in Y32G9A.8.  Lane 1 contains 
Bioline’s Hyperladder DNA marker. Lane 2 contains the positive control, a 500 bp 
mRNA.  Lanes 3-5 contain RT-PCR using the F1 primer as the forward primer.  Lanes 6-
8 contain RT-PCR using the F2 primer.  Lane 9 is a negative control to which no RNA 
was added.  Lane 10 contains Hind III DNA marker. 
 
 
 
 
 
 
 
 
1                    F1              F2                         10
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DISCUSSION 
 Earlier work in the lab showed that a novel gene, Y32G9A.8, was expressed in C. 
elegans and that its function was critical for survival (17). RT-PCR and Northern Dot 
Blot analysis revealed that the gene is expressed in C. elegans at all developmental 
stages.  RNAi experiments suggest that the gene is crucial for normal function in C. 
elegans; animals in the experimental group that survived were lethargic and showed 
delayed response to touch stimuli, and some animals were unable to lay eggs (17).  I was 
interested in extending this knowledge by more precisely determining the location of the 
expression of this gene in C. elegans.  To do this, I created a GFP-promoter fusion, 
microinjected it into worms and observed their offspring for fluorescence at various 
points in their development.  By determining the pattern of expression, I hoped to gain a 
better idea as to the function of this gene.  I also analyzed the alternative transcripts of the 
gene by RT-PCR to help understand the role of the Y32G9A.8 protein in vivo.   
GFP Expression 
Before injecting animals with the GFP reporter construct, I predicted that 
Y32G9A.8 would be expressed in the nervous system.  I based my prediction on previous 
bioinformatics analysis of the genetic sequence.  Expression of the gene was localized to 
the animal’s intestine; this unexpected expression pattern leads me to believe that this 
gene plays a role in the innate immune system of C. elegans.  Because only a small 
segment of the putative promoter was included in the reporter construct (~1400 bp), it is 
possible that including a larger promoter segment would result in a change in the 
expression of GFP.  It may be that the minimal promoter for Y32G9A.8 controls the 
gene’s expression in the gut, while neural expression requires more promoter elements 
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for expression to occur.   Another possibility is that this gene is not expressed in neurons 
at all despite its homology to other neurally expressed DSCAMs. 
 In the future, it may be useful to create a reporter construct using a larger segment 
of the gene’s upstream sequence to observe any changes in the gene’s expression pattern.  
This may be done by designing a PCR primer that lies upstream from the forward PVLR 
primer that was used to create the reporter construct. It would also be very useful to clone 
the reporter-fusion construct into a vector so that subsequent researchers will have the 
construct readily available for future experiments. 
Alternative Splicing 
Many organisms utilize the method of alternative splicing to produce a proteome 
that is much larger than their genome.  This is often necessary in organisms with small 
genomes in order to create complex systems in the body.  Organismal complexity is not 
directly correlated to genome size.  For instance, the human genome is thought to possess 
about 25,000 genes, only about 33% more than the number of genes in C. elegans, 
although C. elegans has much fewer cells (959 somatic cells) than humans.  In order to 
account for the complexity of humans at the genetic level, one must look at the size of the 
human proteome that is produced from these 25,000 genes, not just the number of genes.  
The expansion of the human proteome can be achieved by alternatively splicing pre-
mRNA, thereby allowing a single mRNA to produce more than one protein (23).  The 
resulting proteins are similar but not identical to each other in structure and function and 
could, therefore, provide a wide diversity of proteins needed to ensure proper neural 
arrangement.  Organisms such as Drosophila use alternative splicing to produce a large 
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repertoire of proteins from only a few genes.  C. elegans has also been shown to utilize 
alternative splicing (23).  
 Some gene splicing occurs in response to hormonal or developmental cues; this 
acts as another level of regulation of gene expression (23).  There are several methods for 
producing alternative splice products; these methods include using alternative 5’ splice 
sites, using alternative 3’ splice sites, and the use of mutually exclusive exons or retained 
introns (23).  Changes in a protein’s primary sequence often result from alternative 
splicing events; these changes may be slight or dramatic.  Another result of alternative 
splicing is the production of peptide sequences that are prematurely truncated due to the 
insertion of termination codons in frame (usually due to the insertion of cassette exons) 
(23).  There are several methods that an organism may employ to increase its protein 
repertoire, thus contributing to the solution of having a relatively small genome (23).    
RT-PCR: Analysis of Alternative Splicing in Y32G9A.8 
Total RNA was isolated from a mixed population of him-5 worms using Trizol; 
this RNA was then used as a template for RT-PCR using primers specific for the 
predicted coding region of Y32G9A.8.  The primers were designed to span the entire 
Y32G9A.8 transcript; this was done to determine if there are any alternative splice 
products of this gene.  Because only a single PCR product was produced following RT-
PCR, it is probable that only a single transcript is produced by the Y32G9A.8 gene.  
Before performing RT-PCR, total RNA was electrophoresed on a non-denaturing agarose 
gel to determine if the RNA isolation was successful.  The three prominent bands that 
were present on the gel were believed to correspond to rRNAs.  Because the RNA 
isolation appeared to be successful, the RNA was used in subsequent experiments.  The 
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primer Y32G9A.8-F2 was designed upstream from exon 1, and used with the reverse 
primer Y32G9A.8-R, to ensure that exon 1 is not an alternatively spliced exon.  Because 
this primer set produced only one RT-PCR product that was about 960 bp, it is likely that 
exon 1 is not alternatively spliced.  Possible future directions include analyzing the exon-
intron boundaries in the Y32G9A.8 gene to determine if they follow typical splicing 
patterns.  Because this gene was shown to have only one transcript, it is likely that this 
gene behaves more like a human DSCAM than a Drosophila DSCAM which undergoes 
extensive alternative splicing due to the organization of many groups of mutually 
exclusive exons (10). 
Possible Function of C. elegans DSCAM 
It is possible that the C. elegans DSCAM homolog, like that of Drosophila, has 
developed a dual function, with function in the immune system as well as in neural 
development and axon guidance.   Known antimicrobial genes that are induced by 
pathogenic infection, such as several lysozyme genes, have been shown to be expressed 
mainly in intestinal cells (24).  Because analysis of gene expression suggested that the 
gene is expressed in the worm’s intestine, it is likely that Y32G9A.8 is serving some 
immune function.    The study by Watson et al. (2005) provides support for this scheme 
of one molecule acting in two different systems.  Drosophila, like C. elegans, is an 
invertebrate species that lacks an acquired immune system and thus cannot produce 
antibodies to facilitate an immune response when pathogens are present.  It seems, 
however, that Drosophila has found a way to circumvent this problem by utilizing 
alternative splicing to create a large protein repertoire and by adapting a new function for 
the DSCAM gene (12).   Watson et al. (2005) discovered this possible immune function 
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of DSCAMs in Drosophila by performing immunoprecipitations on fat body extracts; 
they found a soluble form of DSCAM in the fat body extracts.  Fat body cells are an 
important component of Drosophila’s immune system, and the presence of DSCAMs in 
this tissue indicates that these molecules are performing an immune function in addition 
to their neural function, indicating a dual function for the DSCAM gene (12).   
Due to its location in C. elegans, it is likely that Y32G9A.8 has some immune-
related function in the worm.  Tol-1, the toll homolog in C. elegans, is required for 
normal development in C. elegans, and it appears to act in a sensory function, allowing 
the worm to avoid pathogens.  Its’ expression was seen in mechanosensory neurons, thus 
supporting the theory that tol-1 has a sensory role in pathogen avoidance in C. elegans 
(16).  If an animal is unable to detect chemical signals secreted by pathogens, the animal 
is much more likely to become infected with a pathogenic organism.      
Another toll-related gene, tir -1, was identified due to its similarity to tol-1 in a 
conserved intracellular signaling domain, however tir-1 lacks any transmembrane or 
receptor domains (25).  Results from RNAi studies with tir-1 showed that knocking down 
the gene’s function caused several ABF genes to be down-regulated.  RNAi-treated 
animals were also more susceptible to fungal and bacterial infection than wild-type 
animals (25).  There is evidence that C. elegans uses at least some components of a 
conserved signaling pathway (the toll pathway) to deal with innate immunity, and it is 
likely that there are other unrelated molecules (such as DSCAM) that play a similar role 
in the innate immune system.  
  Because bioinformatics analysis of Y32G9A.8 suggests that this gene is an N-
CAM, which is presumably expressed in the nervous system, it is possible that this 
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DSCAM homolog is involved in the innervation of the gut.  This could explain the high 
mortality rate seen in the offspring of RNAi treated animals (17).  If this gene is involved 
in the innervation of the gut, knocking out the gene’s function with RNAi would cause 
the digestive tract to become blocked, thus resulting in the animal’s accelerated death.  
Gene expression analysis showed that, using the GFP reporter that I constructed, 
expression was localized to the animal’s gut.  It is possible that a GFP reporter containing 
a larger upstream sequence would result in GFP expression in neurons surrounding the 
gut as well as the epithelial cells lining the gut.   
Conclusions 
 Results indicate that the genomic organization and structure of the Y32G9A.8 
gene is more similar to mammalian DSCAMs than Drosophila DSCAMs.  Mammals 
usually produce only one or two DSCAM transcripts while Drosophila can have 
thousands of DSCAM transcripts.  RT-PCR analysis revealed that the C. elegans 
DSCAM homolog produces only one transcript; thus, alternative splicing is not taking 
place.  Further analysis, both by molecular methods and bioinformatics, will be necessary 
to more accurately define the nature of the Y32G9A.8 gene in C. elegans. 
 Results of gene expression analysis indicate that the DSCAM in C. elegans may 
play a role similar to the DSCAM homolog in Drosophila.  In Drosophila, studies show 
that DSCAMs are expressed not only in nervous tissue, but also in immune cells 
circulating in the fly’s hemolymph.  Both invertebrates may have developed a method for 
tackling the problem of immunity by taking advantage of genes that already serve 
another, unrelated function in the animal.  
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Future Directions 
 In the future, one could create a larger reporter construct in order to see if the 
gene’s expression pattern changes.  The method of PCR fusion could be used to create 
such a reporter construct quickly, and perhaps create a series of reporters.  This could be 
very helpful in more fully understanding the gene’s expression pattern in vivo.  To test 
the immune function hypothesis, one could infect transgenic animals, expressing a 
promoter driven GFP reporter, with pathogenic bacteria or fungi and look for up-
regulation of GFP expression; such up-regulation of the GFP reporter would indicate that 
the gene is indeed involved in the worm’s innate immune system.         
Another method for analyzing gene expression is in situ hybridization.  This 
method is time consuming and labor intensive, and it would involve creating a labeled 
probe to view the gene’s expression pattern.  Several labeling methods are available for 
in situ hybridization including: autoradiography, fluorescence microscopy, or 
immunohistochemistry.  The latter two methods may be preferred if one wants to avoid 
exposure to radioactivity.  In situ hybridization, like microinjection, would allow one to 
view expression in a whole animal, but animals must be killed and fixed prior to in situ 
hybridization.  Because microinjection has proven to be tricky and unreliable, in situ 
hybridization may be a more reliable method for mapping the gene’s expression pattern; 
this may also help to confirm the expression pattern that was observed using the 
microinjection technique. Another important direction to follow is to isolate the 
Y32G9A.8 protein.  If the protein can be isolated, one may perform a yeast two-hybrid 
screen to look for other proteins that interact with it.  Bioinformatics may prove useful in 
predicting protein-protein interactions; a protein microarray could also be used to analyze 
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proteins that interact with the protein of interest.  If one knows what types of proteins 
interact with the Y32G9A.8 protein, one can learn more about how this gene works.   
Also, isolating the protein could aid in discovering the cellular location of the protein and 
possibly finding out what, if any, signaling pathways involve this protein.    
 If a Y32G9A.8 knockout was available, this would be very useful in more fully 
understanding the gene’s function.  RNAi experiments suggest that the gene is crucial for 
normal development and function in the adult animal, but further experiments would help 
confirm these results and more fully elucidate the gene’s function.  A gene knockout has 
been requested from the C. elegans Gene Knockout Consortium, but is not yet available.   
Once available, a gene knockout could prove very important in more fully characterizing 
this gene.  If a Y32G9A.8 knockout animal had an increased susceptibility to infection by 
pathogens, this would help support the hypothesis that this gene has a role in the worm’s 
immune system.   
 Determining subcellular localization is important for understanding protein 
function.  Several computational tools for determining the subcellular localization of a 
protein are publicly available some of which are:  Target P (http://www.cbs.dtu.dk/ 
services/TargetP/) , which predicts N-terminal sorting signals, and PSORT II 
(http://www.psort.org),  which predicts protein sorting signals and localization sites.  
Creating a translational reporter construct would also be useful in determining the 
subcellular localization of the Y32G9A.8 protein; the reporter gene that was created was 
a transcriptional reporter, so localization of the protein could not be determined using this 
construct.   
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Results from earlier RNAi experiments indicate that this gene is involved in 
coordinating normal movement in C. elegans.  This would indicate that the gene is 
involved in the nervous system.  Because Down Syndrome (DS) in humans is 
characterized by mental retardation, clearly a defect in the nervous system, these results 
support the hypothesis that this gene is related to human DSCAMs.  Down Syndrome in 
humans has several congenital gut diseases that are associated with it.  This might help 
explain the expression pattern that was observed in C. elegans following injection with a 
reporter gene.  Hirschsprung disease, characteristic of individuals with Down Syndrome, 
is a congenital disease in which there are no enteric ganglia along an extended length of 
the intestine (26).  Perhaps a better understanding of this gene in C. elegans will lead to 
advanced treatments for DS-related diseases in humans.      
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